Success of a Comprehensive School-Based Asthma Intervention on Clinical Markers and Resource Utilization for Inner-City Children with Asthma in Chicago: The Mobile C.A.R.E. Foundation's Asthma Management Program

2007 ◽  
Vol 44 (2) ◽  
pp. 113-118 ◽  
Author(s):  
Bina Patel ◽  
Phil Sheridan ◽  
Paul Detjen ◽  
David Donnersberger ◽  
Eric Gluck ◽  
...  
2006 ◽  
Vol 76 (6) ◽  
pp. 291-296 ◽  
Author(s):  
Lynn B. Gerald ◽  
David Redden ◽  
Angelina R. Wittich ◽  
Coralie Hains ◽  
Anne Turner-Henson ◽  
...  

Metabolites ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. 179 ◽  
Author(s):  
Rachel S. Kelly ◽  
Joanne E. Sordillo ◽  
Sharon M. Lutz ◽  
Lydiana Avila ◽  
Manuel Soto-Quiros ◽  
...  

The role of metabolism in modifying age-related differential responses to asthma medications is insufficiently understood. The objective of this study was to determine the role of the metabolome in modifying the effect of age on bronchodilator response (BDR) in individuals with asthma. We used longitudinal measures of BDR and plasma metabolomic profiling in 565 children with asthma from the Childhood Asthma Management Program (CAMP) to identify age by metabolite interactions on BDR. The mean ages at the three studied time-points across 16 years of follow-up in CAMP were 8.8, 12.8, and 16.8 years; the mean BDRs were 11%, 9% and 8%, respectively. Of 501 identified metabolites, 39 (7.8%) demonstrated a significant interaction with age on BDR (p-value < 0.05). We were able to validate two significant interactions in 320 children with asthma from the Genetics of Asthma in Costa Rica Study; 2-hydroxyglutarate, a compound involved in butanoate metabolism (interaction; CAMP: β = −0.004, p = 1.8 × 10−4; GACRS: β = −0.015, p = 0.018), and a cholesterol ester; CE C18:1 (CAMP: β = 0.005, p = 0.006; GACRS: β = 0.023, p = 0.041) Five additional metabolites had a p-value < 0.1 in GACRS, including Gammaminobutyric acid (GABA), C16:0 CE, C20:4 CE, C18.0 CE and ribothymidine. These findings suggest Cholesterol esters and GABA may modify the estimated effect of age on bronchodilator response.


PEDIATRICS ◽  
2006 ◽  
Vol 117 (Supplement 2) ◽  
pp. S145-S151 ◽  
Author(s):  
Rodney B. Boychuk ◽  
Charles J. DeMesa ◽  
Kristi M. Kiyabu ◽  
Franklin Yamamoto ◽  
Loren G. Yamamoto ◽  
...  

10.2196/18977 ◽  
2020 ◽  
Vol 9 (12) ◽  
pp. e18977
Author(s):  
Robin M Dawson ◽  
Sue P Heiney ◽  
DeAnne Hilfinger Messias ◽  
Dennis Ownby

Background Rural Latino children with asthma suffer high rates of uncontrolled asthma symptoms, emergency department visits, and repeat hospitalizations. This vulnerable population must negotiate micro- and macrolevel challenges that impact asthma management, including language barriers, primary care access, parental time off from work, insurance coverage, distance from specialty sites, and documentation status. There are few proven interventions that address asthma management embedded within this unique context. Objective Using a bio-ecological approach, we will determine the feasibility of a patient-centered collaborative program between rural Latino children with asthma and their families, school-based nursing programs, and primary care providers, facilitated by the use of a smartphone-based mobile app with a Spanish-language interface. We hypothesize that improving communication through a collaborative, patient-centered intervention will improve asthma management, empower the patient and family, decrease outcome disparities, and decrease direct and indirect costs. Methods The specific aims of this study include the following: (1) Aim 1: produce and validate a Spanish translation of an existing asthma management app and evaluate its usability with Latino parents of children with asthma, (2) Aim 2: develop and evaluate a triadic, patient-centered asthma intervention preliminary protocol, facilitated by the bilingual mobile app validated in Aim 1, and (3) Aim 3: investigate the feasibility of the patient-centered asthma intervention from Aim 2 using a waiting-list randomized controlled trial (RCT) to investigate the effects of the intervention on school days missed and medication adherence. Results Mobile app translation, initial usability testing, and app software refinement were completed in 2019. Analysis is in progress. Preliminary protocol testing is underway; we anticipate that the waiting-list RCT, using the refined protocol developed in Aim 2, will commence in fall 2020. Conclusions Tailored, technology-based solutions have the potential to successfully address issues affecting asthma management, including communication barriers, accessibility issues, medication adherence, and suboptimal technological interventions. Trial Registration ClinicalTrials.gov NCT04633018; https://www.clinicaltrials.gov/ct2/show/NCT04633018 International Registered Report Identifier (IRRID) DERR1-10.2196/18977


Sign in / Sign up

Export Citation Format

Share Document